NNVC. NanoViricides Reports Its Oral FluCideĀ® Anti-Influenza Drug Candidates Are Superior to Oral Oseltamivir (TamiFluĀ®) in H1N1 Influenza Lethal Infection Model http://finance.yahoo.com/news/nanoviricides-reports-oral-flucide-anti-110000998.html stockcharts.com/c-sc/sc?s=NVC&p=W&yr=1&mn=0&dy=0&i=t53879089772&r=1347275426812